Suchergebnisse - "Cervantes, A"

PubPharm (109)

1

Design and Performance Evaluation of a Fungi-Bacteria Consortium to Biodegrade Organic Matter at High Concentration on Synthetic Slaughterhouse Wastewater

enthalten in: Water, air & soil pollution | 2021

von Robles-Morales, D. | Reyes Cervantes, A. | Díaz-Godínez, R. | +3

2

Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain: results of a subgroup analysis of the phase 3 RECOURSE trial

enthalten in: Clinical & translational oncology | 2017

von Longo-Muñoz, F. | Argiles, G. | Tabernero, J. | +8

3

Fate of Escherichia coli O157:H7 and bacterial diversity in corn silage contaminated with the pathogen and treated with chemical or microbial additives

enthalten in: Journal of dairy science | 2017

von Ogunade, I. | Jiang, Y. | Kim, D. | +6

4

Mutational spectrum of EDA and EDAR genes in a cohort of Mexican mestizo patients with hypohidrotic ectodermal dysplasia

enthalten in: Journal of the European Academy of Dermatology and Venereology | 2017

von Monroy-Jaramillo, N. | Abad-Flores, J. | García-Delgado, C. | +12

5

Abstract P6-11-13: Phase Ib study evaluating the safety and clinical activity of lumretuzumab combined with pertuzumab and paclitaxel in HER2-low metastatic breast cancer

enthalten in: Cancer research | 2017

von Schneeweiss, A. | Park-Simon, T. | Albanell, J. | +22

6

Abstract P6-12-01: Phase II study of taselisib (GDC-0032) plus fulvestrant in HER2-negative, hormone receptor-positive advanced breast cancer: Analysis byPIK3CAandESR1mutation status from circulating tumor DNA

enthalten in: Cancer research | 2017

von Dickler, M. | Saura, C. | Oliveira, M. | +8

7

Mutational spectrum of EDA and EDAR genes in a cohort of Mexican mestizo patients with hypohidrotic ectodermal dysplasia

enthalten in: Journal of the European Academy of Dermatology and Venereology | 2017

von Monroy‐Jaramillo, N. | Abad‐Flores, J. | García‐Delgado, C. | +12

8

In the literature : March 2016

enthalten in: ESMO open | 2016

von Cervantes, A.

9

In the literature : May 2016

enthalten in: ESMO open | 2016

von Cervantes, A.

10

Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer

enthalten in: The British journal of cancer | 2016

von Delaunoit, T. | Varea, R. | Sastre, J. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]